Dynatrace, Inc <DT.N>: Truist Securities raises target price to $60 from $55
DT•Related News
Milestone Scientific Q2 revenue rises 22% on medical segment growth, reaffirms 2026 outlook
MLSS•
Cybin renames key subsidiaries under Helus reorganization plan
CYBN•
French company Lactalis agrees to buy Saputo's UK dairy division
SAP•
Alphabet's SpaceX bet grows 100-fold over a decade to $94 billion
GOOGL•
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
ACXP•